Recall: D-0040-2027
Class II - Potentially Harmful
Class IIClassification
2026-09-25Initiated
OngoingStatus
Houston Rx LLCFirm
Product
Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.
Reason
Lack of assurance of sterility.
Distribution
Nationwide in the USA.
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.